The study included 15 pediatric patients with at least three episodes of C. difficile within a three-month period. Patient follow-up was conducted via phone 24 hours and one week after the procedure. Patients were told to see their gastroenterologist at one and three months post-procedure.
Here are four findings:
1. The study found that 14 out of 15 patients reported no additional episodes more than three months following the procedure.
2. Three patients were hospitalized a month after the procedure for diarrhea, dehydration and rCDI.
3. Only one patient was found to actually have clinical symptoms of C. difficile plus a positive stool test.
4. The study is limited, however, due to the small sample size, among other factors.
More articles on GI/endoscopy:
Mederi Therapeutics launches 3rd generation of Stretta, Boston Scientific reports Q1 2016 financials & more — 5 GI company key notes
Gastroenterologist pay in the US, UK, Canada & Australia: 5 notes
Seres Therapeutics signs research agreements to support development of microbiome therapy for IBD: 3 points
